Answers are grounded in this paper and cite their sources.
Background: The integration of high-risk human papillomavirus (hrHPV) DNA into the host genome contributes to persistent viral infection and malignant progression in hrHPV-related carcinomas, but the integration-associated cis-regulatory programs remain incompletely defined, limiting the identification of potential therapeutic vulnerabilities.We aimed to characterize the regulatory architecture associated with hrHPV integration and evaluate its functional relevance in preclinical models.Methods: Human cervical epithelial organoids carrying integrated HPV16 upstream regulatory region-E6/E7 sequences and an HPV16-integrated mouse model (14 E2.2 HPV16-int ) were established.Viral integration mapping, motif enrichment analysis, chromatin accessibility and histone modification profiling, three-dimensional chromatin interaction analysis, bulk and single-cell transcriptomics, spatial transcriptomics, and patient-derived organoid/xenograft models were integrated to assess integration-associated regulatory changes and pharmacological perturbation.Results: Human epithelial organoids and mice with hrHPV integration recapitulated progressive malignant phenotypes in vitro and in vivo.Across cervical and head and neck cancer datasets, hrHPV integration hotspots were enriched for motifs of a defined subset of 25 HPV-specific stripe transcription factors (HSTFs).Higher HSTF motif density was associated with increased chromatin accessibility, active histone marks, enhanced super-enhancer-promoter interactions, and elevated HSTF regulatory activity along hrHPV-positive epithelial cancer trajectories.Spatial and single-cell multi-omic analyses further confirmed that HSTF activation was triggered by hrHPV integration, which could be blocked by HSTF inhibition in vivo.Conclusions: These findings reveal an hrHPV integration-associated cis-regulatory network that promotes chromatin remodeling and transcriptional activation in HPVdriven carcinogenesis.Targeting HSTF-associated regulatory program may represent a promising therapeutic strategy for hrHPV-integrated precancerous lesions and cancers.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: